Почетна › Мажорна депресивна поремећеност › Arkanzas
Kliničke studije za Мажорна депресивна поремећеност u državi Arkanzas
13 studija za Мажорна депресивна поремећеност traži učesnike na lokacijama u državi Arkanzas.
Gradovi u državi Arkanzas
Zvanični tekst studije (na engleskom)
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Preferred Research Partners, Inc., Little Rock
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 9. 11. 2026. · NCT07592689Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 3. 11. 2026. · NCT06559306A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 3. 11. 2026. · NCT07573176Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Bryant
- Neurocrine Clinical Site, Little Rock
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT06966401Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Woodland Research Northwest (ERG), Rogers
Тражи се учесникФаза 2
Узраст од 18 до 70 · Оба пола · Ажурирано 28. 10. 2026. · NCT07226661Study of ALTO-300 in MDD
- Site 193, Rogers
Тражи се учесникФаза 2
Узраст од 18 до 70 · Оба пола · Ажурирано 26. 10. 2026. · NCT05922878A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Little Rock
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 14. 10. 2026. · NCT07610473A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bentonville
- Draig Clinical Site, Little Rock
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 8. 10. 2026. · NCT07300969Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Little Rock
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 24. 9. 2026. · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Bryant
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT07105111NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Bryant
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 11. 8. 2026. · NCT06911112A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Preferred Research Partners /ID# 279206, Little Rock
- Woodland International Research Group /ID# 277605, Little Rock
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 15. 6. 2026. · NCT07276997Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Little Rock
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2025. · NCT06786624Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.